for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Japan Tissue Engineering Co., Ltd.

7774.T

Latest Trade

841.00JPY

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

686.00

 - 

1,230.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
841.00
Open
--
Volume
--
3M AVG Volume
1.15
Today's High
--
Today's Low
--
52 Week High
1,230.00
52 Week Low
686.00
Shares Out (MIL)
40.61
Market Cap (MIL)
34,478.06
Forward P/E
326.54
Dividend (Yield %)
--

Next Event

Q3 2020 Japan Tissue Engineering Co Ltd Earnings Release

Latest Developments

More

Japan Tissue Engineering to sign patent licensing agreement with Nagoya University and Shinshu University

Japan Tissue Engineering to sell patent of Autologous Cultured Cartilage in China for 300 mln yen

Fujifilm's regenerative medicine unit appears to be on track to generate profit for FY ending March - Nikkei

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Japan Tissue Engineering Co., Ltd.

Japan Tissue Engineering Co., Ltd. is a Japan-based company principally engaged in the development, manufacture and sale of tissue-engineered medical products (TEPs) and related products. The Company operates its business in two segments. The TEP segment is engaged in the research and development of self-cultured epidermis, self-cultured cartilages and self-cultured corneal epithelium for medical institutions. The Research and Development Supports segment is engaged in the development, manufacture and sale of laboratory human cultured tissues based on tissue engineering technology and manufacturing know-how for cosmetic and pharmaceutical product manufacturers.

Industry

Biotechnology & Drugs

Contact Info

6-209-1, Miyakita-dori

+81.533.662020

http://www.jpte.co.jp

Executive Leadership

Kenichiro Hata

Chairman of the Executive Board, Representative Director

Masataka Akiyama

Executive President, Representative Director

Toshihiro Ohsuka

Senior Managing Executive Officer, Chief Senior Director of Production, Director

Toshiyuki Hara

Managing Executive Officer, Chief Director of Business Administration, Director of General Affairs & Human Resources, Director

Masukazu Inoie

Executive Officer, Director of Research & Development

Key Stats

2.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2020(E)

0.0K
EPS (JPY)

2020(E)

2.120
Price To Earnings (TTM)
--
Price To Sales (TTM)
14.87
Price To Book (MRQ)
4.51
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
-2.43
Return on Equity (TTM)
-2.25

Latest News

Latest News

BRIEF-Japan Tissue Engineering to sell patent of Autologous Cultured Cartilage in China for 300 mln yen

* Says it plans to sell the patent of a type of Autologous Cultured Cartilage in China for 300 million yen

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up